5 completed, 2 active not recruiting. 7 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 5, Active not recruiting 2 |
| Phase 2 | 3 | Completed 2, Active not recruiting 1 |
Follow Type1diabetes: new trials by email Literature Review of Type1diabetes trials Research Report on Type1diabetes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors SGLT-2 inhibitor - Diabetes, Type1diabetes | Phase 1 | Completed | McGill University | 24 | 2024-12-05 | 2026-09-25 |
| Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes Hyperinsulinemic-euglycemic clamp, High Fat Mixed Meal Tolerance Test - type1diabetes, Obesity | Phase 1 | Active not recruiting | Yale University | 15 | 2023-12-13 | 2026-07-23 |
| Butyrate Adjuvant Therapy for Type 1 Diabetes BKR-017 - Type1diabetes | Phase 1 / Phase 2 | Completed | Mayo Clinic | 6 | 2022-07-28 | 2026-03-31 |
| Mesenchymal Stromal Cells to Treat Type 1 Diabetes in Children and Adolescents the ATMP Protrans - Type1diabetes | Phase 1 / Phase 2 | Active not recruiting | Uppsala University Hospital | 66 | 2022-01-14 | 2026-04-28 |
| Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed with Type I Diabetes ProTrans, Control - Type1diabetes | Phase 1 / Phase 2 | Completed | NextCell Pharma Ab | 15 | 2019-05-17 | 2025-03-07 |
| Three Way Crossover Closed Loop Study With Xeris Glucagon Artificial Pancreas Controller in Dual Hormone Mode, Artificial Pancreas Controller in Single Hormone Mode, Artificial Pancreas Controller in Predictive Low Glucose Suspend Mode - Type1diabetes | Phase 1 | Completed | Oregon Health and Science University | 23 | 2018-03-29 | 2020-05-27 |
| Pilot Study to Explore the Efficacy of DAPAglifozin as add-on to Closed-loop Control in Patients With Type 1 Diabetes Dapagliflozin, Placebo Oral Tablet - Type1diabetes | Phase 1 | Completed | Kinderkrankenhaus auf der Bult | 30 | 2017-02-09 | 2024-10-15 |
Diabetes Mellitus (2) · Motor Activity (2) · Diabetes Mellitus, Type 1 (1) · Obesity (1)
Nutritional and Metabolic Diseases (3) · Behavior (2) · Endocrine System Diseases (2) · Glucose Metabolism Disorders (2) · Metabolic Diseases (2) · Autoimmune Diseases (1) · Body Weight (1) · Immune System Diseases (1) · Nutrition Disorders (1) · Overnutrition (1) · Overweight (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Butyrates (1) · Sodium-Glucose Transporter 2 Inhibitors (1) · Transplantation, Homologous (1) · dapagliflozin (1) · empagliflozin (1)
Kinderkrankenhaus auf der Bult (1) · Mayo Clinic (1) · McGill University (1) · NextCell Pharma Ab (1) · Oregon Health and Science University (1) · Uppsala University Hospital (1) · Yale University (1)
United States (3) · Sweden (2) · Canada (1) · Germany (1)
Adrian Vella, MD (1) · Jessica Castle, MD (1) · Michael Tsoukas, M.D. (1) · Michelle Van Name, MD (1) · Per-Ola Carlsson, MD, PhD (1) · Per-Ola Carlsson, PhD (1) · Thomas Danne, MD (1)
2018 (1), R01DK134398 (1)